Apyx Medical Corp. (NASDAQ: APYX) reported Q3 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $11.38 million.

GUIDANCE:

Apyx Medical Corp. sees FY2024 revenue of $46.6-47.6 million, versus the consensus of $50.76 million.

Apyx Medical Corp. sees FY2024 revenue of $47.6-49.5 million, versus the consensus of $54.14 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.